Actively Recruiting

Phase Not Applicable
Age: 18Years - 99Years
All Genders
NCT06048510

New Markers of Glycation to Predict Gestational Diabetes Mellitus and Macrosomia.

Led by University Hospital, Bordeaux · Updated on 2026-01-15

800

Participants Needed

1

Research Sites

245 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Bordeaux

Lead Sponsor

S

Société Francophone du Diabète

Collaborating Sponsor

AI-Summary

What this Trial Is About

Gestational diabetes mellitus (GDM) increases the risk of macrosomia and other adverse pregnancy outcomes. Screening strategies are debated: universal vs. selective, and macrosomia may begin before the time of screening, suggesting that glycation markers may have an interest. The objective of this trail is to compare novel markers: skin autofluorescence and glycated albumin, to HbA1c (reference) as predictors of GDM, macrosomia and other adverse outcomes, in pregnant women.

CONDITIONS

Official Title

New Markers of Glycation to Predict Gestational Diabetes Mellitus and Macrosomia.

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Singleton pregnancy or twin pregnancy reduced spontaneously or medically before 14 weeks of amenorrhea
  • Gestational age less than 28 weeks of amenorrhea at inclusion
  • Participant affiliated with or beneficiary of a social security scheme
  • Patient consent obtained
Not Eligible

You will not qualify if you...

  • Gestational age 28 weeks or more of amenorrhea at inclusion
  • Multiple pregnancy
  • Known diabetes before pregnancy
  • History of bariatric surgery
  • Expected delivery in a maternity unit not participating in the study
  • Person deprived of liberty by judicial or administrative decision
  • Under guardianship or curatorship
  • Not affiliated with or not benefiting from a social security scheme

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hopital Pellegrin

Bordeaux, France, 33000

Actively Recruiting

Loading map...

Research Team

F

FOUSSARD NINON, Dr

CONTACT

R

RIGALLEAU VINCENT, Pr

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here